Approval · Notice of Compliance 2581 · 2001
GEREF: Notice of Compliance 2581
Issued June 22, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2581
- Date
- June 22, 2001
- Company
- Serono Canada Inc.
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New strengths; new route; new indication - therapeutic use of new strengths and route for treatment of idiopathic growth hormone deficiency in children with growth failure
- Therapeutic class
- Growth hormone releasing hormone - therapeutic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| GEREF | 02244003 | — |
| GEREF | 02244004 | — |
Medicinal ingredients
- SERMORELIN ACETATE 0.5 MG per VIAL
- SERMORELIN ACETATE 1 MG per VIAL